Analysts Viewpoint
Arcutis Biotherapeutics Inc [ARQT] Shares Jump Approximately 79.05% Over the Year
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Arcutis Biotherapeutics Inc’s filing revealed that its Director Heron Patrick J acquired Company’s shares for reported $25177.0 on Jun 04
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Arcutis Biotherapeutics Inc’s recently made public that its insider Matsuda Masaru unloaded Company’s shares for reported $24807.0 on May 28
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Arcutis Biotherapeutics Inc’s recent filing unveils that its Director Heron Patrick J acquired Company’s shares for reported $34317.0 on May
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Arcutis Biotherapeutics
In a filing, Arcutis Biotherapeutics Inc revealed its insider Matsuda Masaru unloaded Company’s shares for reported $76453.0 on May 02